Open label phase II clinical trial of orteronel (TAK700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The Greko II study-GETHI 201301

Date issued
2015Journal title
Journal Of Clinical Oncology
Type of content
Publicación de congreso
